Aktie A113TU VIADERMA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen ViaDerma, Inc. Other OTC

Aktien

A113TU

US92555K1016

VDRM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
CapitalGainsReport: Top Stocks Under Two Cents To Radar Today (ATVK, VDRM, RNVA, ELTP)
BigTime Penny Stocks: Potential Break-Out Stocks to Watch (DPUI, RCIT, VDRM)
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More 
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product
ViaDerma Provides an Update on Current & Future Business Activities
ViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth Online
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products
ViaDerma, Inc. Successfully Completes Quality Control Testing of Its New Vitastem Products
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
ViaDerma : Annual Report
ViaDerma : Attorney Letter with Respect to Current Information
ViaDerma : Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
ViaDerma, Inc. Set to Launch Two New and Improved Versions of Its Flagship Product, Vitastem and Vitastem Ultra
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A113TU Aktie
  4. A113TU Aktie
  5. Nachrichten ViaDerma, Inc.
  6. Andere Sprachen